1. Home
  2. NXPLW vs RDUS Comparison

NXPLW vs RDUS Comparison

Compare NXPLW & RDUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXPLW
  • RDUS
  • Stock Information
  • Founded
  • NXPLW N/A
  • RDUS 1906
  • Country
  • NXPLW United States
  • RDUS United States
  • Employees
  • NXPLW 166
  • RDUS N/A
  • Industry
  • NXPLW Telecommunications Equipment
  • RDUS Industrial Specialties
  • Sector
  • NXPLW Telecommunications
  • RDUS Consumer Discretionary
  • Exchange
  • NXPLW Nasdaq
  • RDUS Nasdaq
  • Market Cap
  • NXPLW N/A
  • RDUS N/A
  • IPO Year
  • NXPLW N/A
  • RDUS 1993
  • Fundamental
  • Price
  • NXPLW $0.12
  • RDUS $16.57
  • Analyst Decision
  • NXPLW
  • RDUS Hold
  • Analyst Count
  • NXPLW 0
  • RDUS 2
  • Target Price
  • NXPLW N/A
  • RDUS $22.00
  • AVG Volume (30 Days)
  • NXPLW N/A
  • RDUS 172.6K
  • Earning Date
  • NXPLW N/A
  • RDUS 01-02-2025
  • Dividend Yield
  • NXPLW N/A
  • RDUS 4.59%
  • EPS Growth
  • NXPLW N/A
  • RDUS N/A
  • EPS
  • NXPLW N/A
  • RDUS N/A
  • Revenue
  • NXPLW N/A
  • RDUS $2,738,692,000.00
  • Revenue This Year
  • NXPLW N/A
  • RDUS $4.65
  • Revenue Next Year
  • NXPLW N/A
  • RDUS $0.17
  • P/E Ratio
  • NXPLW N/A
  • RDUS N/A
  • Revenue Growth
  • NXPLW N/A
  • RDUS N/A
  • 52 Week Low
  • NXPLW N/A
  • RDUS $12.69
  • 52 Week High
  • NXPLW N/A
  • RDUS $31.70
  • Technical
  • Relative Strength Index (RSI)
  • NXPLW N/A
  • RDUS 35.79
  • Support Level
  • NXPLW N/A
  • RDUS $18.02
  • Resistance Level
  • NXPLW N/A
  • RDUS $19.60
  • Average True Range (ATR)
  • NXPLW 0.00
  • RDUS 0.99
  • MACD
  • NXPLW 0.00
  • RDUS -0.38
  • Stochastic Oscillator
  • NXPLW 0.00
  • RDUS 5.57

About NXPLW NextPlat Corp

NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.

Share on Social Networks: